Affiliation:
1. Department of Neuropharmacology, Glaxo Group Research Ltd., Ware, Herts., SG12 0DJ, UK
Abstract
Abstract
The effect of the opioid antagonist, 16-methylcyprenorphine (RX8008M), on the antinociceptive action of the μ-selective agonist, morphine, and the κ-selective agonist, U50488H, has been investigated in the mouse abdominal constriction test. RX8008M produced a dose-dependent antagonism of the antinociceptive effect of morphine, but did not antagonize the response to U50488H. RX8008M should prove a useful probe for the in-vivo characterization of the receptor selectivity of opioid drugs.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference8 articles.
1. Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by β-funaltrexamine;Hayes;J. Pharmacol. Exp. Ther.,1987
2. The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog;Martin;J. Pharmacol. Exp. Ther.,1976
3. Binaltorphimine and norbinaltorphimine, potent and selective κ-opioid receptor antagonists;Portoghese;Life Sci.,1987
4. Pharmacological evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in-vitro;Shook;J. Pharmacol. Exp. Ther.,1987
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献